Japanese scientist Tasuku Honjo, a winner of the Nobel Prize in physiology or medicine in 2018, is fighting over patent royalty rate against Ono Pharmaceutical, a Japanese pharmaceutical company. Background Reportedly, in 2006, Honjo and Ono entered a license agreement for the patents on PD-1 which was applied to the cancer drug Opdivo (nivolumab). However, […]